These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


517 related items for PubMed ID: 11231573

  • 1. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.
    Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC.
    Nat Cell Biol; 2001 Mar; 3(3):245-52. PubMed ID: 11231573
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients.
    Xia W, Chen JS, Zhou X, Sun PR, Lee DF, Liao Y, Zhou BP, Hung MC.
    Clin Cancer Res; 2004 Jun 01; 10(11):3815-24. PubMed ID: 15173090
    [Abstract] [Full Text] [Related]

  • 3. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T, Luoh SW.
    Carcinogenesis; 2008 Mar 01; 29(3):473-9. PubMed ID: 17916906
    [Abstract] [Full Text] [Related]

  • 4. Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway.
    Comalada M, Xaus J, Sánchez E, Valledor AF, Celada A.
    Eur J Immunol; 2004 Aug 01; 34(8):2257-67. PubMed ID: 15259023
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
    Kominsky SL, Hobeika AC, Lake FA, Torres BA, Johnson HM.
    Cancer Res; 2000 Jul 15; 60(14):3904-8. PubMed ID: 10919667
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R.
    Mol Carcinog; 2004 Nov 15; 41(3):164-78. PubMed ID: 15390078
    [Abstract] [Full Text] [Related]

  • 7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 8. Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast.
    Sastre-Garau X, Genin P, Rousseau A, Al Ghuzlan A, Nicolas A, Fréneaux P, Rosty C, Sigal-Zafrani B, Couturier J, Thiery JP, Magdelénat H, Vincent-Salomon A.
    Histopathology; 2004 Aug 15; 45(2):142-7. PubMed ID: 15279632
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
    Hermanová M, Lukás Z, Nenutil R, Brázdil J, Kroupová I, Kren L, Pazourková M, Růzicka M, Díte P.
    Neoplasma; 2004 Aug 15; 51(2):77-83. PubMed ID: 15190415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA, Mehmi I, Lupu R.
    Int J Oncol; 2005 Mar 15; 26(3):649-59. PubMed ID: 15703820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma.
    Cohen BD, Siegall CB, Bacus S, Foy L, Green JM, Hellström I, Hellström KE, Fell HP.
    Biochem Soc Symp; 1998 Mar 15; 63():199-210. PubMed ID: 9513724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.
    Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, Hung MC.
    Cancer Res; 2000 Dec 15; 60(24):6841-5. PubMed ID: 11156376
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.